As healthcare professionals, it is essential to have a deep understanding of chronic diseases that affect a significant proportion of the population. One such condition is Parkinson's disease (PD), a neurodegenerative disorder that primarily affects movement control.
PD is characterized by the loss of dopamine-producing neurons in the substantia nigra, a region of the brain that regulates movement. The exact cause of this neuronal loss is unknown, but it is likely due to a combination of genetic and environmental factors. The accumulation of alpha-synuclein, a protein that forms Lewy bodies, is a hallmark of PD.
The cardinal symptoms of PD include resting tremor, bradykinesia, rigidity, and postural instability. Non-motor symptoms such as depression, cognitive impairment, and autonomic dysfunction may also occur. The disease progression is typically slow, taking years or even decades.
Diagnosis of PD is primarily clinical, based on the presence of characteristic motor symptoms and the response to dopaminergic therapy. Neuroimaging techniques like DaTSCAN can provide supportive evidence but are not required for diagnosis.
While there is currently no cure for PD, treatment aims to manage symptoms and improve quality of life. Pharmacological therapy, primarily with levodopa, is the mainstay of treatment. Other options include dopamine agonists, MAO-B inhibitors, and deep brain stimulation in advanced cases.
Healthcare professionals play a crucial role in the management of PD. This includes early detection, initiation and optimization of therapy, and monitoring for disease progression and complications. Multidisciplinary care involving neurologists, physiotherapists, occupational therapists, and mental health professionals is often required.
In conclusion, PD is a complex neurodegenerative disorder with a multifaceted clinical presentation. An in-depth understanding of its pathogenesis, clinical features, diagnosis, and management strategies is crucial for healthcare professionals to provide optimal care to patients with PD.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation